Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K2 | P36507 | 8/20 | 0.40 |
| ▸ | MAP2K1 | Q02750 | 8/20 | 0.40 |
| ▸ | KDM5A | P29375 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17540401 | 0.83 | KDM5A (0.33) | MAP2K2MAP2K1KDM5AKDM4ENPC1 | |
| SCHEMBL17540395 | 0.81 | DGAT1 (0.41) | MAP2K2MAP2K1KDM5AKDM4ENPC1 | |
| SCHEMBL16122058 | 0.78 | MAP2K2 (0.42) | MAP2K2MAP2K1KDM4EALDH1A1DGAT1 | |
| SCHEMBL17540400 | 0.77 | MAPT (0.43) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL17540384 | 0.73 | KDM4E (0.44) | KDM4ENPC1ALDH1A1PKMRAB9A | |
| SCHEMBL17761393 | 0.73 | MAP2K1 (0.46) | MAP2K2MAP2K1DGAT1ROCK2 | |
| SCHEMBL17540399 | 0.67 | CA1 (0.34) | KDM5A | |
| SCHEMBL2612359 | 0.65 | KDM4E (0.58) | KDM4ENPC1ALDH1A1PKMRAB9A | |
| SCHEMBL19532029 | 0.65 | MAP2K2 (0.37) | MAP2K2MAP2K1DGAT1 | |
| SCHEMBL7806435 | 0.65 | KDM5A (0.45) | KDM5AKDM4ENPC1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313650-A1 | SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | UDC IRELAND LIMITED (IE) | 2017-11-02 | — | — | US | disclosed |
| US-9718764-B2 | Synthetic building blocks for the production of materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2017-08-01 | — | — | US | disclosed |
| US-20160046563-A1 | SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | UDC IRELAND LIMITED (IE) | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046563-A1 | SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | TBCB, CYBA, BMP2 | MAP2K2 2978/4885MAP2K1 3209/4885KDM5A 3063/4885 |
| US-20170313650-A1 | SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | TBCB, CYBA, BMP2 | MAP2K2 2978/4885MAP2K1 3209/4885KDM5A 3063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.